Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Injection for Fecal Incontinence After Rectal Cancer Surgery
NCT04063293Phase 1Unknown
- Sponsor
- Medipol Mega University Hospital
- Start
- May 2019
- Primary completion
- Aug 2020
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous platelet-rich plasma in fecal incontinence (FI), sponsored by Medipol Mega University Hospital. Primary endpoint: Wexner fecal incontinence score change at 6 months. Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT04063293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04063293.